DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Oxaprotiline
Oxaprotiline
Still the Leading Antidepressant After 40
Still the Leading Antidepressant After 40 Years of Randomised Controlle
Tcas Versus Placebo - New Studies in the Guideline Update
Resume of Scientific Contributions to Psychopharmacology And
Pjp2'2002.Vp:Corelventura
Development of New Antidepressants Eleni Palazidou
Centre for Reviews and Dissemination
Maois in the Contemporary Treatment of Depression Michael E
Supplemental Digital Content 1 Search Strategy (First Conducted on January 17, 2014; Second Retrieval on November 5, 2014)
United States Patent (10) Patent No.: US 9,572.814 B2 Casseday Et Al
Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania: a Multiple-Treatments Meta-Analysis
(12) United States Patent (10) Patent No.: US 7,915,307 B2 Casseday Et Al
Pharmacogenetics of Antidepressants and Antipsychotics
Combination of a Sedative and a Neurotransmitter Modulator, and Methods for Improving Sleep Quality and Treating Depression
Selective Increase of Dopamine D3 Receptor Gene Expression As A
Neurobiological Similarities in Depression and Drug Dependence: a Self-Medication Hypothesis Athina Markou, Ph.D., Thomas R
Still the Leading Antidepressant After 40 Years of Randomised Controlled Trials CORRADO BARBUI and MATTHEW HOTOPF BJP 2001, 178:129-144
Antidepressant Treatment of Depression in Schizophrenia: a Systematic Review and Meta-Analysis
Top View
Activity in Discrete Rat Brain Regions
Reboxetine for Treating Migraine Headaches Reboxetin Zur Behandlung Von Migränekopfschmerzen Reboxétine Pour Traiter Les Migraines
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
ICD-10-CM Table of Drugs 2019
Comparative Anticholinergic Activity of Oxaprotiline and Amitriptyline
United States Patent (19) 11 Patent Number: 5,922,341 Smith Et Al
Effects of Antidepressants